|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 119 of 141 found articles
| Title: |
P61 Sustained reduction in confirmed disability progression in patients with primary progressive multiple sclerosis treated with ocrelizumab in the open-label extension period of the Phase III ORATORIO trial |
| Author: |
Wolinsky, J.S. Hartung, H.P. Brochet, B. Montalban, X. Naismith, R.T. Manfrini, M. Garas, M. Model, F. Hubeaux, S. Kappos, L. Hauser, S.L. |
| Appeared in: |
Clinical neurophysiology |
| Paging: | Volume 130 (2019) nr. 8 pages e170-e171 |
| Year: |
2019 |
| Contents: | |
| Publisher: |
Published by Elsevier B.V. |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 119 of 141 found articles
| << previous | next >> |